Evidence map›Paper›PMID 42116673›Full record

ArticleXenotransplantation

Early Experimental Report of the First 8-Gene-Edited Pig-to-Rhesus Macaque Cardiac Xenotransplantation in China.

Xianzhi Wang, Xijie Wu, Ziqiang Dai, Licheng Yan, Jie Yan, Dongsheng He, Shangxuan Li, Zhipeng Ren, Gen Zhang, Guanzheng Cui and 8 more

Abstract read
In one paragraph

Article in Xenotransplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Xianzhi WangDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.ORCID https://orcid.org/0000-0002-2442-1577
Xijie WuDepartment of Cardiovascular Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Institute of Cardiovascular Disease, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
Ziqiang DaiDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.
Licheng YanDepartment of Cardiovascular Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Institute of Cardiovascular Disease, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
Jie YanChengdu ClonOrgan Biotechnology Co, Ltd., Chengdu, China.
Dongsheng HeDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.
Shangxuan LiDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.ORCID https://orcid.org/0009-0008-1831-1145
Zhipeng RenDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.
Gen ZhangDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.
Guanzheng CuiDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.ORCID https://orcid.org/0009-0005-3551-1980
Xin LiDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.
Xianhua LiFirst People's Hospital of Neijiang, Neijiang, China.
Yulong GuanExtracorporeal Circulation Center, National Cardiovascular Disease Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0002-3609-0197
Guangyu PanDepartment of Cardiovascular Surgery, People's Hospital of Peking University, Beijing, China.
Ik Jin YunDepartment of Surgery, Konkuk University Hospital, Seoul, South Korea.
Wensheng ZhouSIP-UCLA Institute for Technology Advancement, Suzhou, China.
Dengke PanChengdu ClonOrgan Biotechnology Co, Ltd., Chengdu, China.
Dianyuan LiDepartment of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.ORCID https://orcid.org/0009-0009-7101-0859

Funding

National Key R&D Program of China 2024YFC3406800Noncommunicable Chronic Diseases-National Science and Technology Major Project 2025ZD0552100Suzhou Gusu Health Talent Program GSWS2022065Suzhou "Science and Education Strengthening Medicine" Project QNXM2024033
6 · The paper itself

Abstract

objectivesThis study aimed to investigate the functional recovery of an 8-gene-edited pig heart after orthotopic xenotransplantation, the characteristics of the recipient's immune responses, and the efficacy of postoperative complication management to provide comprehensive experimental evidence for the clinical translation of xenogeneic cardiac transplantation technology.

methodsOn December 27, 2025, an orthotopic heart was xenotransplanted from an 8-gene-edited pig to a rhesus macaque using the biatrial anastomosis technique. Postoperatively, comprehensive vital sign monitoring, immunosuppressive therapy, and complication interventions were implemented. Donor organ cardiac function, recipient immune indicators, and survival status were evaluated within 30 days after transplantation.

resultsThe recipient macaque survived for more than 30 days postoperatively. The cardiac function of the donor heart gradually stabilized, with the ejection fraction increasing from 58% in the early postoperative phase to 66%. No hyperacute immune rejection occurred. Postoperative complications, including infection, pleural effusion, and blood pressure fluctuations, were effectively controlled with symptomatic treatment.

conclusionsAn 8-gene-edited pig heart demonstrates good biocompatibility in xenogeneic cardiac transplantation. Standardized surgical procedures, precise immunosuppressive regimens, and comprehensive postoperative care can effectively ensure desirable transplantation outcomes. This study offers an important technical reference for clinical xenogeneic cardiac transplantation.

Indexed as

Heart TransplantationHeterograftsTransplantation, HeterologousAnimalsAnimals, Genetically ModifiedChinaFemaleGraft RejectionGraft SurvivalMacaca mulattaSwinecardiac transplantationimmunosuppressionxenotransplantation

Identifiers

PMID42116673
PMCPMC13161745

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.